Choi J - Search Results

1

Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.

Oh BK, Kim YJ, Park YN, Choi J, Kim KS, Park C. Oh BK, et al. Among authors: choi j. Am J Gastroenterol. 2006 Apr;101(4):831-8. doi: 10.1111/j.1572-0241.2006.00532.x. Epub 2006 Feb 22. Am J Gastroenterol. 2006. PMID: 16494581

2

Expression of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in intraductal and nonintraductal growth type of cholangiocarcinoma.

Jo Chae K, Rha SY, Oh BK, Koo JS, Kim YJ, Choi J, Park C, Park YN. Jo Chae K, et al. Among authors: choi j. Am J Gastroenterol. 2004 Jan;99(1):68-75. doi: 10.1046/j.1572-0241.2003.04025.x. Am J Gastroenterol. 2004. PMID: 14687144

3

The role of splenectomy in patients with hepatocellular carcinoma and secondary hypersplenism.

Oh JW, Ahn SM, Kim KS, Choi JS, Lee WJ, Kim BR. Oh JW, et al. Yonsei Med J. 2003 Dec 30;44(6):1053-8. doi: 10.3349/ymj.2003.44.6.1053. Yonsei Med J. 2003. PMID: 14703616 Free article.

4

Postoperative liver regeneration and complication in live liver donor after partial hepatectomy for living donor liver transplantation.

Kwon KH, Kim YW, Kim SI, Kim KS, Lee WJ, Choi JS. Kwon KH, et al. Yonsei Med J. 2003 Dec 30;44(6):1069-77. doi: 10.3349/ymj.2003.44.6.1069. Yonsei Med J. 2003. PMID: 14703618 Free article.

5

Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype.

Kim H, Park C, Han KH, Choi J, Kim YB, Kim JK, Park YN. Kim H, et al. Among authors: choi j. J Hepatol. 2004 Feb;40(2):298-304. doi: 10.1016/j.jhep.2003.10.023. J Hepatol. 2004. PMID: 14739102

6

Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.

Park YN, Chae KJ, Oh BK, Choi J, Choi KS, Park C. Park YN, et al. Among authors: choi j, choi ks. Hepatogastroenterology. 2004 Mar-Apr;51(56):396-400. Hepatogastroenterology. 2004. PMID: 15086168

7

Percutaneous cholecystostomy using a central venous catheter is effective for treating high-risk patients with acute cholecystitis.

Park SH, Kang CM, Chae YS, Kim KS, Choi JS, Lee WJ, Kim BR. Park SH, et al. Surg Laparosc Endosc Percutan Tech. 2005 Aug;15(4):202-8. doi: 10.1097/01.sle.0000174551.71801.5a. Surg Laparosc Endosc Percutan Tech. 2005. PMID: 16082306

8

Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.

Lee JD, Yang WI, Park YN, Kim KS, Choi JS, Yun M, Ko D, Kim TS, Cho AE, Kim HM, Han KH, Im SS, Ahn YH, Choi CW, Park JH. Lee JD, et al. J Nucl Med. 2005 Oct;46(10):1753-9. J Nucl Med. 2005. PMID: 16204727 Free article.

9

The actual five-year survival rate of hepatocellular carcinoma patients after curative resection.

Lee JG, Kang CM, Park JS, Kim KS, Yoon DS, Choi JS, Lee WJ, Kim BR. Lee JG, et al. Yonsei Med J. 2006 Feb 28;47(1):105-12. doi: 10.3349/ymj.2006.47.1.105. Yonsei Med J. 2006. PMID: 16502491 Free PMC article.

10

Inflammatory pseudotumor of the liver treated by hepatic resection: a case report.

Kim YW, Lee JG, Kim KS, Yoon DS, Lee WJ, Kim BR, Shin EA, Park YN, Choi JS. Kim YW, et al. Yonsei Med J. 2006 Feb 28;47(1):140-3. doi: 10.3349/ymj.2006.47.1.140. Yonsei Med J. 2006. PMID: 16502497 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,936 results

Search Page

Filters